Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPublications section updated to clarify PubMed auto-fill and the revision tag updated to v3.3.2.SummaryDifference0.0%

- Check21 days agoChange DetectedThe government funding status notice at the top of the page has been removed. It previously stated that the NIH Clinical Center is open and provided links to operating status updates.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded two Taiwan sites in Tainan (704 and 736) and removed the corresponding Tainan City entries (704 and 736) from the Locations section.SummaryDifference0.0%

- Check35 days agoChange DetectedThe changes are limited to administrative updates such as the last updated date and minor formatting; there are no changes to core study information like eligibility criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedSummary: The page now displays a government funding lapse notice and new operating status details accompanying a version upgrade to v3.2.0, replacing the old v3.1.0.SummaryDifference1.0%

- Check71 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.1%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.